{"id":1068260,"date":"2022-06-09T01:55:14","date_gmt":"2022-06-09T05:55:14","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/cerevance-to-participate-in-panel-discussion-during-the-2022-bio-international-convention\/"},"modified":"2024-08-18T11:45:04","modified_gmt":"2024-08-18T15:45:04","slug":"cerevance-to-participate-in-panel-discussion-during-the-2022-bio-international-convention","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/cerevance-to-participate-in-panel-discussion-during-the-2022-bio-international-convention.php","title":{"rendered":"Cerevance to Participate in Panel Discussion During the 2022 BIO International Convention"},"content":{"rendered":"<p><![CDATA[BOSTON, June  08, 2022  (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system (CNS) diseases, today announced that Craig Thompson, chief executive officer of Cerevance, will participate in a panel discussion during the 2022 BIO International Convention being held in San Diego, CA, June 13-16. Mr. Thompson will present at the panel titled, \u201cCNS drug development: Do biomarkers hold the future for patients?\u201d and will share his insights on the future of neurological drug development alongside other leading CNS experts in the life sciences industry.]]><\/p>\n<p>See the article here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/08\/2458949\/0\/en\/Cerevance-to-Participate-in-Panel-Discussion-During-the-2022-BIO-International-Convention.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Cerevance to Participate in Panel Discussion During the 2022 BIO International Convention\">Cerevance to Participate in Panel Discussion During the 2022 BIO International Convention<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the article here: Cerevance to Participate in Panel Discussion During the 2022 BIO International Convention <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/cerevance-to-participate-in-panel-discussion-during-the-2022-bio-international-convention.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068260","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068260"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068260"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068260\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068260"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068260"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}